Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Clene Inc.

NASDAQ: CLNN · Life Sciences · 5 alerts · CIK 1822791

Share price
$3.66Close, Nov 16
Market cap
$52.7M
Shares outstanding
14.4MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Clene Inc. filings on SEC EDGAR ↗

6:02 AM ET 8-K
Business Update

Clene Business Update

Clene Inc. entered into a subaward amendment with NYU for the fourth year of a previously announced NIH grant, providing up to $7.2 million in funding. The grant supports an Expanded Access Program for the company's CNM-Au8 treatment for amyotrophic lateral sclerosis (ALS). This represents the final year of a total $45.1 million four-year grant awarded under the ACT for ALS Act.

Counterparty
New York University
Term
Sept 2026 to Aug 2027
8:05 AM ET 8-K
Business Update

Clene Business Update

Clene Inc. has submitted a New Drug Application (NDA) to the FDA seeking accelerated approval for CNM-Au8 for the treatment of amyotrophic lateral sclerosis (ALS). The submission is based on neurofilament light chain biomarker data and clinical outcomes, with the company also preparing for a confirmatory Phase 3 RESTORE-ALS study.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.